# CVE-2026-8833: XSS in urls

> Authenticated users can inject malicious URLs to execute scripts in other users' browsers, potentially leading to account takeover.

- **Severity:** High 8.5 (`CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:H/VI:H/VA:H/SC:N/SI:L/SA:N`)
- **Exploited in the wild:** Not known
- **Login needed:** Any signed-in user
- **Attackable:** Over the internet
- **Victim action needed:** A user has to click or open something
- **Fix available:** No
- **Published:** 8 Jun 2026
- **Updated:** 8 Jun 2026
- **Also known as:** GHSA-hc7p-6r8x-vr4q, UBUNTU-CVE-2026-8833

## What is CVE-2026-8833?

CVE-2026-8833 is a high-severity cross-site scripting vulnerability in Checkmk Checkmk, published on 8 Jun 2026. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link.

### Official description

Improper neutralization of HTML-encoded characters in the URL validation function in Checkmk <2.5.0p5, <2.4.0p31, <2.3.0p48, and all 2.2.0 versions allows an authenticated user to bypass URL validation and inject malicious URLs such as javascript: URIs, resulting in cross-site scripting when another user interacts with the crafted link.

Weakness: CWE-79 (Improper Neutralization of Input During Web Page Generation)

## Which versions are affected by CVE-2026-8833?

It affects 1 product.


Products: Checkmk Checkmk.

## How do I fix CVE-2026-8833?

No fix has been published for CVE-2026-8833 yet. Limit exposure of the affected software until one is available.

## Is CVE-2026-8833 being exploited?

There is no known exploitation of CVE-2026-8833 in the wild and no public exploit code.

## Other vulnerabilities in Checkmk Checkmk

- [CVE-2025-39666](https://insights.sbomify.com/CVE-2025-39666/): omd: Local privilege escalation when executing omd commands as root (critical 9.3)
- [CVE-2024-8606](https://insights.sbomify.com/CVE-2024-8606/): Fix 2FA bypass via RestAPI (critical 9.2)
- [CVE-2022-46836](https://insights.sbomify.com/CVE-2022-46836/): PHP code injection in watolib (critical 9.1)
- [CVE-2025-32919](https://insights.sbomify.com/CVE-2025-32919/): Privilege Escalation in Windows License plugin for Checkmk Windows Agent (high 8.8)
- [CVE-2024-28827](https://insights.sbomify.com/CVE-2024-28827/): Privilege escalation in Windows agent (high 8.8)

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2026-8833 and fix it if it is affected.

What it is: CVE-2026-8833 is a high-severity cross-site scripting vulnerability in Checkmk Checkmk, published on 8 Jun 2026. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link.
Exploitation: There is no known exploitation of CVE-2026-8833 in the wild and no public exploit code.

Affected product: Checkmk Checkmk. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2026-8833/ (Markdown: https://insights.sbomify.com/CVE-2026-8833/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2026-8833
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2026-8833
- OSV: https://osv.dev/vulnerability/CVE-2026-8833

---
From sbomify Insights: https://insights.sbomify.com/CVE-2026-8833/
Summaries are generated and may contain mistakes; the official description above is the record.